Quantum Biopharma (QNTM) Assets Average (2022 - 2026)

Quantum Biopharma has disclosed Assets Average across 4 years of filings, most recently posting $13.0 million for Q1 2026.

• Assets Average for Q1 2026 came in at $13.0 million, down 18.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (down 18.46% YoY), and the FY2025 annual result was $14.1 million, down 18.25% from the prior year.
• Assets Average came in at $13.0 million for Q1 2026 at Quantum Biopharma, up from $12.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $63.0 million in Q1 2022 to a low of $12.7 million in Q4 2025.
• The 4-year median for Assets Average is $17.1 million (2024), against an average of $31.5 million.
• Peak annual rise in Assets Average reached 14.07% in 2025, while the deepest fall reached 29.97% in 2025.
• Quantum Biopharma's Assets Average stood at $50.7 million in 2022, then slumped by 64.34% to $18.1 million in 2024, then retreated by 29.97% to $12.7 million in 2025, then increased by 3.05% to $13.0 million in 2026.
• The last three Assets Average figures came in at $13.0 million (Q1 2026), $12.7 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.